Attached files
| file | filename |
|---|---|
| 10-K - AEOLUS PHARMACEUTICALS 10-K - AEOLUS PHARMACEUTICALS, INC. | aeolus10k.htm |
| EX-32.1 - EXHIBIT 32.1 - AEOLUS PHARMACEUTICALS, INC. | exh32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - AEOLUS PHARMACEUTICALS, INC. | exh31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - AEOLUS PHARMACEUTICALS, INC. | exh31_1.htm |
| EX-23.2 - EXHIBIT 23.2 - AEOLUS PHARMACEUTICALS, INC. | exh23_2.htm |
| EX-21.1 - EXHIBIT 21.1 - AEOLUS PHARMACEUTICALS, INC. | exh21_1.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-1 (File No. 333-209119) and the Registration Statement on Form S-8 (File No. 333-190770) of Aeolus Pharmaceuticals, Inc. (the "Company") of our report dated December 20, 2016, relating to our audit of the Company's consolidated financial statements as of September 30, 2016, and for the year then ended, included in the Company's Annual Report on Form 10-K for the year ended September 30, 2016.
HASKELL & WHITE LLP
Irvine, California
December 20, 2016